SourceCF Clinical Research and Development Announces = the Licensing of a New Aerosol Delivery Platform

SourceCF Clinical Research and Development = Announces the=20 Licensing of a New Aerosol Delivery Platform
Monday December 8, 4:24 pm ET=20

SourceCF Focuses=20 Solely On Improving Cystic Fibrosis Treatments=20

HUNTSVILLE, Ala., Dec. 8 /PRNewswire/ -- SourceCF = Clinical=20 Research and Development, a Huntsville, Alabama-based company that = focuses=20 on the development of products for people affected by Cystic = Fibrosis=20 (CF), announces the licensing through one of its wholly owned = subsidiaries=20 of a novel aerosol delivery platform -- the eFlow=AE Electronic = Inhaler=20 (PARI GmbH) for specific programs to be announced later.

"While=20 many medications in CF are delivered via inhalation," states Geoff = Hunziker, Senior Vice President for the PARI Aerosol Research = Institute,=20 USA, "treatment times are often as long as 15 to 20 minutes and = can limit=20 patient compliance and the positive benefits that can be = associated with=20 these therapies." In-vitro studies conducted with the eFlow=AE = have=20 demonstrated up to a four fold reduction in treatment times.
Mike Walters, Managing Director of SourceCF Clinical Research = and=20 Development, states, "we are excited with these in-vitro data and = the=20 significant reduction in nebulization times seen with the use of = the=20 eFlow=AE Electronic Inhaler". Walters added, "We have already = initiated=20 several programs around this platform." Based on feedback from = FDA, the=20 company is optimistic that it can begin patient trials using this = device=20 in early 2004.
About SourceCF Clinical Research and Development: The new = company was=20 formed to serve the Cystic Fibrosis community through the = development of=20 new treatment options aimed at improving the lives of people = living with=20 this disease. "We are excited to serve the Cystic Fibrosis = Community in=20 this way" said Michael Walters, President and CEO of SourceCF. = "Life=20 expectancy continues to increase through new options and = approaches to=20 care delivery and large-scale clinical trials are needed to = support this=20 important work," Walters added. For more information, visit http://www.sourcecf.com/
About The PARI Aerosol Research Institute: As a division that = falls=20 under the PARI umbrella, the PARI Aerosol Research Institute (ARI) = is the=20 research and development arm of the company focused on new aerosol = delivery technologies and pharmaceutical formulation of = medications=20 including in-vitro aerosol characterization to predict in-vivo = drug=20 deposition. The ARI places special emphasis on the interaction = between the=20 drug and device with the focus being on the patient.
PARI is a long established company founded in 1906 in Germany = that=20 focuses on highly efficient aerosol delivery products for patients = with=20 respiratory diseases. For more information, visit http://www.pari.de/
About CF: Cystic fibrosis is a genetic disease affecting = approximately=20 30,000 children and adults in the United States. One in 31 = Americans (one=20 in 28 Caucasians) - more than 10 million people - is an unknowing, = symptom-less carrier of the defective gene. CF causes the body to = produce=20 abnormally thick, sticky mucus, due to the faulty transport of = sodium and=20 chloride (salt) within cells lining organs such as the lungs and = pancreas,=20 to their outer surfaces. CF has a variety of symptoms. The most = common=20 include: very salty- tasting skin; persistent coughing, wheezing = or=20 pneumonia; excessive appetite but poor weight gain; and bulky = stools.=20 Treatment of CF depends upon the stage of the disease and which = organs are=20 involved. For more information, visit http://www.cff.org/=20

Source: SourceCF

Email=20 this story - Set a = News=20 Alert

ADVERTISEMENT

Sponsored = Links

WeRL= oans.com,=20 Mortgage Loans All Types
Mortgage loans, all types. A+ and = bad=20 credit. Cash out, straight talk. No gimmick = loans. Easy=20 applications. Real rate quotes. Safe and=20 secure.
www.werloans.com

Champion=20 - Find a Mortgage Now
You've worked hard for your home. = Let=20 Champion show you how it can work hard for you. = Looking=20 to refinance, get a home mortgage or a line of = credit,=20 Champion says yes. Act now.
www.championmortgage.com

Home=20 Mortgage from Full Spectrum = Lending
Cut monthly payments, = get needed=20 cash or buy a new home with a home mortgage = loan. We're=20 part of Countrywide, one of the nation's leading = independent home lenders.
www.fullspectrumlending.com
(What's=20 = This?)